Comparative assessment of the diagnostic value of neopterin and acute phase proteins in angiographically assessed stable coronary artery disease

Basit Öğe Kaydı
dc.contributor.authorGulmen, B
dc.contributor.authorTurgan, N
dc.contributor.authorKayikcioglu, M
dc.contributor.authorOzmen, D
dc.contributor.authorErsoz, B
dc.contributor.authorKultursay, H
dc.date.accessioned2019-10-27T19:05:14Z
dc.date.available2019-10-27T19:05:14Z
dc.date.issued2004
dc.departmentEge Üniversitesien_US
dc.description.abstractAssessment of markers of systemic inflammation, such as acute-phase reactants C-reactive protein (CRP), fibrinogen and ceruloplasmin, sialic acid, a major component of these proteins and neopterin, a specific marker of cellular immune activation, in clinically stable coronary artery disease, may contribute to staging and risk stratification. These markers were measured in 225 consecutive stable coronary artery disease patients before undergoing coronary angiography. According to their angiographic scores 32 patients were designated as having minor, 34 moderate and 96 severe coronary artery disease. 63 patients with negative angiograms were taken as the anglographic controls. High sensitive-CRP (hs-CRP) and fibrinogen were found to be higher in patients with angiographically established coronary artery disease, than in angiographic controls (p < 0.05) and correlated with the severity and extent of disease. Ceruloplasmin and sialic acid concentrations did not differ between patients with and without angiographically established coronary artery disease. Serum neopterin levels were sigificantly higher in patients undergoing coronary angiography than in healthy controls. Neopterin levels were similar between the different subgroups of coronary artery disease, suggesting that neopterin determinations do not contribute to the assessment of the presence and severity of disease in clinically stable patients. In stable angina, serum hs-CRP and plasma fibrinogen levels proved to be more effective than ceruloplasmin, sialic acid and neopterin in discriminating between patients with positive and negative angiograms and various degrees of coronary artery disease, thus in pointing out to increased risk. Our results, do not support the inclusion of neopterin in risk assessment of stable coronary artery disease.en_US
dc.identifier.endpage43en_US
dc.identifier.issn0933-4807
dc.identifier.issn0933-4807en_US
dc.identifier.issue1en_US
dc.identifier.scopusqualityQ4en_US
dc.identifier.startpage33en_US
dc.identifier.urihttps://hdl.handle.net/11454/38272
dc.identifier.volume15en_US
dc.identifier.wosWOS:000221890100005en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherWalter De Gruyter Gmbhen_US
dc.relation.ispartofPteridinesen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectneopterinen_US
dc.subjectacute phase proteinsen_US
dc.subjectC-reactive proteinen_US
dc.subjectceruloplasminen_US
dc.subjectfibrinogenen_US
dc.subjectsialic aciden_US
dc.subjectrisk assessmenten_US
dc.subjectcoronary angiographyen_US
dc.subjectstable coronary artery diseaseen_US
dc.titleComparative assessment of the diagnostic value of neopterin and acute phase proteins in angiographically assessed stable coronary artery diseaseen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu